All stocks / MDXR
MEDICAL EXERCISE INC. MDXR
Medical Exercise (MDXR): a late 10-Q notice in November 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- MEDICAL EXERCISE INC
- Market tier
- OTC Pink Limited
- Trading status
- Active
- Website
- www.medar.com
The financial report, and what it means
Annual figures to 2026-03-31- Net loss
- ($226,708)
It spends more than it earns
Under strainThe company lost $226,708 in the year. It reported no sales.
- Cash and cash equivalents
- $43,449
- Net cash used in operating activities
- ($194,751)
The cash could run out soon
Under strainIt had $43,449 in the bank and used about $16,229 a month. At that pace the money lasts about 3 months unless it borrows or sells more shares.
- Total assets
- $61,330
- Total liabilities
- $244,837
It owes more than it owns
Under strainEverything the company owns adds up to $61,330. Its debts and unpaid bills add up to $244,837. That is about $3.99 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Filed NT 10-Q on 2026-11-13: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Estimated float about 13,327,000 shares as of 2026-08-19: 13,327,000 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Filed NT 10-Q on 2026-08-14: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Filed NT 10-Q on 2025-11-17: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
| 2026-11-13 | NT 10-Q | NOTIFICATION OF LATE FILING |
| 2026-08-19 | 10-Q | QUARTERLY REPORT |
| 2026-08-14 | NT 10-Q | NOTIFICATION OF LATE FILING |
| 2026-06-29 | 10-K | ANNUAL REPORT |
| 2026-05-19 | D | |
| 2026-05-18 | D/A | |
| 2026-05-15 | D/A | |
| 2026-05-08 | 8-K | CURRENT REPORT |
| 2026-05-08 | 8-K/A | AMENDMENT NO. 1 TO FORM 8-K |
| 2026-02-27 | D | |
| 2026-02-13 | 10-Q | QUARTERLY REPORT |
| 2026-02-05 | SCHEDULE 13G |
Common questions about MDXR
Does MDXR file reports with the SEC?
Yes. Medical Exercise files with the SEC under company number 0002001249. The most recent filing we hold is a NT 10-Q dated 2026-11-13.
Source recordHow many MDXR shares are outstanding?
13,327,000 shares as of 2026-08-19, as reported to the SEC.
Source recordHas MDXR filed reports late?
Yes. In the last 12 months it filed 3 late-filing notices, most recently a NT 10-Q on 2026-11-13. A notice means a report was not ready on time; check whether the report followed.
Source recordWho runs Medical Exercise?
Officers named in its insider filings: Matthew John Degelman (President).
Source recordIs Medical Exercise making money?
The company lost $226,708 in the year. It reported no sales. (Annual figures to 2026-03-31. Facts from the company's own report, not a recommendation.)
Source record